Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Hemodynamic Effects of Late Sodium Current Inhibitors in a Swine Model of Heart Failure.

Goldstein RE, Klein MG, Ouimet SP, Shou M, Hood MN, Flagg TP, Haigney MC.

J Card Fail. 2019 Oct;25(10):828-836. doi: 10.1016/j.cardfail.2019.08.015. Epub 2019 Aug 25.

PMID:
31461671
2.

A meta-analysis of the efficacy of cognitive behavior therapy on quality of life and psychological health of breast cancer survivors and patients.

Ye M, Du K, Zhou J, Zhou Q, Shou M, Hu B, Jiang P, Dong N, He L, Liang S, Yu C, Zhang J, Ding Z, Liu Z.

Psychooncology. 2018 Jul;27(7):1695-1703. doi: 10.1002/pon.4687. Epub 2018 Mar 26.

PMID:
29500842
3.

Role of suppression of the inward rectifier current in terminal action potential repolarization in the failing heart.

Klein MG, Shou M, Stohlman J, Solhjoo S, Haigney M, Tidwell RR, Goldstein RE, Flagg TP, Haigney MC.

Heart Rhythm. 2017 Aug;14(8):1217-1223. doi: 10.1016/j.hrthm.2017.04.001. Epub 2017 Apr 8.

PMID:
28396172
4.

High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study.

Sun S, He L, Bai M, Liu H, Li Y, Li L, Yu Y, Shou M, Jing R, Zhao L, Huang C, Wang H.

Ann Saudi Med. 2015 Sep-Oct;35(5):352-8. doi: 10.5144/0256-4947.2015.352.

5.

Simultaneous Enantioseparation of Aldohexoses and Aldopentoses Derivatized With L-Tryptophanamide by Reversed Phase HPLC Using Butylboronic Acid as a Complexation Reagent of Monosaccharides.

Shou M, Terashima H, Aizawa S, Taga A, Yamamoto A, Kodama S.

Chirality. 2015 Jul;27(7):417-21. doi: 10.1002/chir.22456. Epub 2015 May 20.

PMID:
25994510
6.

[Current status and future prospect of pre- and post-operative adjuvant therapy of pancreatic cancer: discussion].

Unno M, Ueno H, Honda G, Satoi S, Shou M, Tani S, Motoi F.

Nihon Shokakibyo Gakkai Zasshi. 2011 Oct;108(10):1676-95. Japanese. No abstract available.

PMID:
23035336
7.

A novel biotransformation of alkyl aminopyrrolidine to aminopiperidine ring by human CYP3A.

Chen Y, Skiles GL, Shou M, Hickman D, Hsieh F.

Drug Metab Dispos. 2011 Sep;39(9):1668-73. doi: 10.1124/dmd.111.039750. Epub 2011 Jun 14.

PMID:
21673127
8.

Simulation of clinical drug-drug interactions from hepatocyte CYP3A4 induction data and its potential utility in trial designs.

Xu Y, Zhou Y, Hayashi M, Shou M, Skiles GL.

Drug Metab Dispos. 2011 Jul;39(7):1139-48. doi: 10.1124/dmd.111.038067. Epub 2011 Mar 25.

PMID:
21441468
9.

Development and validation of a stability-indicating RP-HPLC method for assay of betamethasone and estimation of its related compounds.

Fu Q, Shou M, Chien D, Markovich R, Rustum AM.

J Pharm Biomed Anal. 2010 Feb 5;51(3):617-25. doi: 10.1016/j.jpba.2009.09.034. Epub 2009 Sep 30.

PMID:
19846264
10.

Prediction of human drug-drug interactions from time-dependent inactivation of CYP3A4 in primary hepatocytes using a population-based simulator.

Xu L, Chen Y, Pan Y, Skiles GL, Shou M.

Drug Metab Dispos. 2009 Dec;37(12):2330-9. doi: 10.1124/dmd.108.025494. Epub 2009 Sep 22.

PMID:
19773538
11.

Development and validation of a stability-indicating HPLC method for simultaneous determination of salicylic acid, betamethasone dipropionate and their related compounds in Diprosalic Lotion.

Shou M, Galinada WA, Wei YC, Tang Q, Markovich RJ, Rustum AM.

J Pharm Biomed Anal. 2009 Oct 15;50(3):356-61. doi: 10.1016/j.jpba.2009.05.015. Epub 2009 May 23.

PMID:
19545962
13.

Antibodies as a probe in cytochrome P450 research.

Shou M, Lu AY.

Drug Metab Dispos. 2009 May;37(5):925-31. doi: 10.1124/dmd.108.025718. Epub 2009 Feb 5. Review.

PMID:
19196844
14.

Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transporters.

Chu XY, Liang Y, Cai X, Cuevas-Licea K, Rippley RK, Kassahun K, Shou M, Braun MP, Doss GA, Anari MR, Evers R.

Pharm Res. 2009 Feb;26(2):459-68. doi: 10.1007/s11095-008-9799-5. Epub 2008 Dec 11.

PMID:
19082692
15.

Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.

Ma S, Subramanian R, Xu Y, Schrag M, Shou M.

Drug Metab Dispos. 2008 Dec;36(12):2414-8. doi: 10.1124/dmd.108.023085. Epub 2008 Sep 17.

PMID:
18799804
16.

Modeling, prediction, and in vitro in vivo correlation of CYP3A4 induction.

Shou M, Hayashi M, Pan Y, Xu Y, Morrissey K, Xu L, Skiles GL.

Drug Metab Dispos. 2008 Nov;36(11):2355-70. doi: 10.1124/dmd.108.020602. Epub 2008 Jul 31.

PMID:
18669588
17.

Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions.

Yang J, Liao M, Shou M, Jamei M, Yeo KR, Tucker GT, Rostami-Hodjegan A.

Curr Drug Metab. 2008 Jun;9(5):384-94. Review.

PMID:
18537575
18.

The rate of intravenous cocaine administration alters c-fos mRNA expression and the temporal dynamics of dopamine, but not glutamate, overflow in the striatum.

Ferrario CR, Shou M, Samaha AN, Watson CJ, Kennedy RT, Robinson TE.

Brain Res. 2008 May 13;1209:151-6. doi: 10.1016/j.brainres.2008.02.081. Epub 2008 Mar 7.

19.

Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.

Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR, Kennedy RT, Rebec GV.

Neuroscience. 2008 Apr 22;153(1):329-37. doi: 10.1016/j.neuroscience.2008.02.004. Epub 2008 Feb 15.

20.

Impact of pH on plasma protein binding in equilibrium dialysis.

Kochansky CJ, McMasters DR, Lu P, Koeplinger KA, Kerr HH, Shou M, Korzekwa KR.

Mol Pharm. 2008 May-Jun;5(3):438-48. doi: 10.1021/mp800004s. Epub 2008 Mar 18.

PMID:
18345638
21.

Muscarinic modulation of the sodium-calcium exchanger in heart failure.

Wei SK, Ruknudin AM, Shou M, McCurley JM, Hanlon SU, Elgin E, Schulze DH, Haigney MC.

Circulation. 2007 Mar 13;115(10):1225-33. Epub 2007 Mar 5.

PMID:
17339552
22.

Monitoring dopamine in vivo by microdialysis sampling and on-line CE-laser-induced fluorescence.

Shou M, Ferrario CR, Schultz KN, Robinson TE, Kennedy RT.

Anal Chem. 2006 Oct 1;78(19):6717-25.

PMID:
17007489
23.

The role of P-glycoprotein in the bioactivation of raloxifene.

Chang JH, Kochansky CJ, Shou M.

Drug Metab Dispos. 2006 Dec;34(12):2073-8. Epub 2006 Sep 7.

PMID:
16959878
24.

Microdialysis coupled on-line to capillary liquid chromatography with tandem mass spectrometry for monitoring acetylcholine in vivo.

Shackman HM, Shou M, Cellar NA, Watson CJ, Kennedy RT.

J Neurosci Methods. 2007 Jan 15;159(1):86-92. Epub 2006 Jul 28.

PMID:
16876256
25.

Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes.

Carr B, Norcross R, Fang Y, Lu P, Rodrigues AD, Shou M, Rushmore T, Booth-Genthe C.

Drug Metab Dispos. 2006 Oct;34(10):1703-12. Epub 2006 Jun 30.

PMID:
16815964
26.

CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16.

Stabile E, Kinnaird T, la Sala A, Hanson SK, Watkins C, Campia U, Shou M, Zbinden S, Fuchs S, Kornfeld H, Epstein SE, Burnett MS.

Circulation. 2006 Jan 3;113(1):118-24. Epub 2005 Dec 27. Erratum in: Circulation. 2006 Apr 18;113(15):e711.

PMID:
16380545
27.

Microfluidic electrophoresis chip coupled to microdialysis for in vivo monitoring of amino acid neurotransmitters.

Sandlin ZD, Shou M, Shackman JG, Kennedy RT.

Anal Chem. 2005 Dec 1;77(23):7702-8.

PMID:
16316179
28.

Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey.

Shou M, Lu W, Kari PH, Xiang C, Liang Y, Lu P, Cui D, Emary WB, Michel KB, Adelsberger JK, Brunner JE, Rodrigues AD.

Eur J Pharm Sci. 2005 Oct;26(2):151-61.

PMID:
16085400
29.

Prediction of pharmacokinetics and drug-drug interactions from in vitro metabolism data.

Shou M.

Curr Opin Drug Discov Devel. 2005 Jan;8(1):66-77. Review.

PMID:
15679174
30.

Selective inhibition of dog hepatic CYP2B11 and CYP3A12.

Lu P, Singh SB, Carr BA, Fang Y, Xiang CD, Rushmore TH, Rodrigues AD, Shou M.

J Pharmacol Exp Ther. 2005 May;313(2):518-28. Epub 2005 Jan 26.

PMID:
15677349
31.

Sulfotransferase 1E1 is a low km isoform mediating the 3-O-sulfation of ethinyl estradiol.

Schrag ML, Cui D, Rushmore TH, Shou M, Ma B, Rodrigues AD.

Drug Metab Dispos. 2004 Nov;32(11):1299-303.

PMID:
15483196
32.

Influence of different recombinant systems on the cooperativity exhibited by cytochrome P4503A4.

Zhang Z, Li Y, Shou M, Zhang Y, Ngui JS, Stearns RA, Evans DC, Baillie TA, Tang W.

Xenobiotica. 2004 May;34(5):473-86.

PMID:
15370963
33.
34.

Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor.

Zhou YF, Stabile E, Walker J, Shou M, Baffour R, Yu Z, Rott D, Yancopoulos GD, Rudge JS, Epstein SE.

J Am Coll Cardiol. 2004 Aug 18;44(4):897-903.

35.

The impact of cytochrome P450 allosterism on pharmacokinetics and drug-drug interactions.

Shou M.

Drug Discov Today. 2004 Aug 1;9(15):636-7. No abstract available.

PMID:
15279845
36.

In vitro and in vivo metabolism of a potent and selective integrin alpha v beta 3 antagonist in rats, dogs, and monkeys.

Cui D, Subramanian R, Shou M, Yu X, Wallace MA, Braun MP, Arison BH, Yergey JA, Prueksaritanont T.

Drug Metab Dispos. 2004 Aug;32(8):848-61.

PMID:
15258111
37.

Validation of (-)-N-3-benzyl-phenobarbital as a selective inhibitor of CYP2C19 in human liver microsomes.

Cai X, Wang RW, Edom RW, Evans DC, Shou M, Rodrigues AD, Liu W, Dean DC, Baillie TA.

Drug Metab Dispos. 2004 Jun;32(6):584-6.

PMID:
15155548
38.

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.

Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE.

Circulation. 2004 Mar 30;109(12):1543-9. Epub 2004 Mar 15. Erratum in: Circulation. 2005 Jul 26;112(4):e73.

PMID:
15023891
39.

Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development.

Lee CW, Stabile E, Kinnaird T, Shou M, Devaney JM, Epstein SE, Burnett MS.

J Am Coll Cardiol. 2004 Feb 4;43(3):474-82.

40.

Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain.

Mast N, Norcross R, Andersson U, Shou M, Nakayama K, Bjorkhem I, Pikuleva IA.

Biochemistry. 2003 Dec 9;42(48):14284-92.

PMID:
14640697
41.

Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit.

Stabile E, Zhou YF, Saji M, Castagna M, Shou M, Kinnaird TD, Baffour R, Ringel MD, Epstein SE, Fuchs S.

Circ Res. 2003 Nov 28;93(11):1059-65. Epub 2003 Nov 6.

PMID:
14605018
42.

Monoclonal antibodies to cytochromes P450.

Gelboin HV, Shou M, Goldfarb I, Yang TJ, Krausz K.

Methods Mol Biol. 1998;107:227-37. No abstract available.

PMID:
14577233
43.

Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.

Lu P, Schrag ML, Slaughter DE, Raab CE, Shou M, Rodrigues AD.

Drug Metab Dispos. 2003 Nov;31(11):1352-60.

PMID:
14570767
44.

Solvent effect on cDNA-expressed human sulfotransferase (SULT) activities in vitro.

Ma B, Shou M, Schrag ML.

Drug Metab Dispos. 2003 Nov;31(11):1300-5.

PMID:
14570759
45.

Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450.

Shou M, Norcross R, Sandig G, Lu P, Li Y, Lin Y, Mei Q, Rodrigues AD, Rushmore TH.

Drug Metab Dispos. 2003 Sep;31(9):1161-9.

PMID:
12920172
46.

Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice.

Stabile E, Burnett MS, Watkins C, Kinnaird T, Bachis A, la Sala A, Miller JM, Shou M, Epstein SE, Fuchs S.

Circulation. 2003 Jul 15;108(2):205-10. Epub 2003 Jun 23.

PMID:
12821542
47.

Laser myocardial revascularization modulates expression of angiogenic, neuronal, and inflammatory cytokines in a porcine model of chronic myocardial ischemia.

Fuchs S, Baffour R, Vodovotz Y, Shou M, Stabile E, Tio FO, Leon MB, Kornowski R.

J Card Surg. 2002 Sep-Oct;17(5):413-24.

PMID:
12630542
48.

Kinetic analysis for multiple substrate interaction at the active site of cytochrome P450.

Shou M.

Methods Enzymol. 2002;357:261-76. No abstract available.

PMID:
12424916
49.

Inhibition kinetics of monoclonal antibodies against cytochromes P450.

Mei Q, Tang C, Lin Y, Rushmore TH, Shou M.

Drug Metab Dispos. 2002 Jun;30(6):701-8.

PMID:
12019198
50.

Could plasmid-mediated gene transfer into the myocardium be augmented by left ventricular guided laser myocardial injury?

Fuchs S, Baffour R, Shou M, Stabile E, Singh S, Schwartz B, Branellec D, Epstein SE, Kornowski R.

Catheter Cardiovasc Interv. 2001 Dec;54(4):533-8.

PMID:
11747197

Supplemental Content

Support Center